Recenzija, prikaz

Mohs Surgery Outside Usual Indications: A Review

Pedro Rodríguez-Jiménez ; Dermatology department, Hospital Universitario de la Princesa, Madrid, Spain
Alejandra Reolid ; Dermatology department, Hospital Universitario de la Princesa, Madrid, Spain
Philip Brabyn ; Oral and maxillofacial surgery department, Hospital Universitario de la Princesa, Madrid, Spain
Elena Gallo ; Dermatology department, Hospital Universitario de la Princesa, Madrid, Spain
Raquel Navarro ; Dermatology department, Hospital Universitario de la Princesa, Madrid, Spain
Yolanda Delgado Jiménez ; Dermatology department, Hospital Universitario de la Princesa, Madrid, Spain

Sažetak

The body of literature supporting the use of Mohs micrographic surgery (MMS) in tumors outside the main indications (basal cell
carcinoma, squamous cell carcinoma, dermatofibrosacroma protuberans, lentigo maligna) is constantly growing, but it is still based on case reports, case series, or at best institutional case series that focus on a single
malignancy. Our aim in this review was to assess use of MMS in an array of
rare tumors outside the usual indications. A review was performed using
the MEDLINE database and the search engine ClinicalKey®. We reviewed
the use of MMS on atypical fibroxanthoma (AFX)/malignant fibrous histiocytoma, microcystic adnexal carcinoma, extramammary Paget’s disease, Merkel cell carcinoma, pocrine/eccrine carcinoma/porocarcinoma,
trichilemmal carcinoma, leiomyosarcoma, and angiosarcoma. Mohs micrographic surgery appears to be scarcely used in these tumors due to
their low incidence. It is mainly performed for tumors in the H-zone of
the face, and can be performed safely. The overall recurrence rate is lower
compared with simple or wide local excision. MMS should be used in a
more generalized fashion for these tumors.

Ključne riječi

Mohs surgery; micrographic surgery; skin cancer; skin tumors

Hrčak ID:

280214

URI

https://hrcak.srce.hr/280214

Datum izdavanja:

30.12.2020.

Posjeta: 763 *